Relative levels of IL4 and IFN-γ in complicated malaria: Association with IL4 polymorphism and peripheral parasitemia

Acta Tropica

Volumn 101, Issue 3, 2007, Pages 258-265

  Tangteerawatana, Piyatida ^a   Pichyangkul, Sathit ^c   Hayano, Masashi ^d   Kalambaheti, Thareerat ^a   Looareesuwan, Sornchai ^b   Troye Blomberg, Marita ^d   Khusmith, Srisin ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

IFN ; IL4; IL4 polymorphism; Inflammatory cytokine; P. falciparum; Severity

Indexed keywords

ANTIMALARIAL AGENT; CYTOKINE; DNA; GAMMA INTERFERON; HEMOGLOBIN VARIANT; INTERLEUKIN 4;

ALLELE; DISEASE CONTROL; DISEASE SEVERITY; GENOTYPE; IMMUNOASSAY; INVERSE ANALYSIS; MALARIA; PARASITISM; POLYMORPHISM; PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEPATOMEGALY; HUMAN; MALARIA; MALE; PARASITEMIA; POLYMERASE CHAIN REACTION; PROGNOSIS; SPLENOMEGALY; THAILAND; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX;

ASIA; EURASIA; SOUTHEAST ASIA; THAILAND;

PLASMODIUM FALCIPARUM;

EID: 34047158318     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2007.02.008     Document Type: Article

References (35)

1. Abdel-Razzak Z., Loyer P., Fautrel A., Gautier J., Corcos L., Turlin B., Beaune P., and Guillouzo A. Cytokines down regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol. Pharmacol. 44 (1993) 707-715
2. Alloueche A., Silveira H., Conway D., Bojang K., Doherty T., Cohen J., Pinder M., and Greenwood B. High-throughput sequence typing of T-cell epitope polymorphisms in Plasmodium falciparum circumsporozoite protein. Mol. Biochem. Parasitol. 106 (2000) 273-282
3. Banchereau J., Briere F., Galizzi J., Miossec P., and Rousset F. Human interleukin 4. J. Lipid. Mediat. Cell. Signal. 9 (1994) 43-53
4. Borish L., Mascali J.J., Klinnert M., Leppert M., and Rosenwasser L.J. SSC polymorphisms in interleukin genes. Hum. Mol. Genet. 4 (1995) 974
5. Chaisavaneeyakorn S., Othoro C., Shi Y., Otieno J., Chaiyaroj S., Lal A., and Udhayakumar V. Relationship between plasma Interleukin-12 (IL-12) and IL-18 levels and severe malarial anemia in an area of holoendemicity in western Kenya. Clin. Diagn. Lab. Immunol. 10 (2003) 362-366
6. Chuang L., Tai T., Kahn R., Wu H., Lee S., and Lin B. Signal transduction pathways for interleukin 4 and insulin in human hepatoma cells. J. Biochem. (Tokyo) 120 (1996) 111-116
7. Day N., Hien T., Schollaardt T., Loc P., Chuong L., Chau T., Mai N., Phu N., Sinh D., White N., and Ho M. The prognostic and pathophysiologic role of pro- and anti-inflammatory cytokines in severe malaria. J. Infect. Dis. 180 (1999) 1288-1297
8. Farouk S., Dolo A., Bereczky S., Kouriba B., Maiga B., Farnert A., Perlmann H., Hayano M., Montgomery S., Doumbo O., and Troye-Blomberg M. Different antibody- and cytokine-mediated responses to Plasmodium falciparum parasite in two sympatric ethnic tribes living in Mali. Microbes Infect. 7 (2005) 110-117
9. Fell A., Currier J., and Good M. Inhibition of Plasmodium falciparum growth in vitro by CD4+ and CD8+ T cells from non-exposed donors. Parasite Immunol. 16 (1994) 579-586
10. Gyan B., Goka B., Cvetkovic J., Kurtzhals J., Adabayeri A., Perlmann H., Lefvert A., Akanmori B., and Troye-Blomberg M. Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children. Clin. Exp. Immunol. 138 (2004) 145-150
11. Hansen D., Siomos M., De Koning-Ward T., Buckingham L., Crabb B., and Schofield L. CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses. Eur. J. Immunol. 33 (2003) 2588-2598
12. Harpaz R., Edelman R., Wasserman S., Levine M., Davis J., and Sztein M. Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge. J. Clin. Invest. 90 (1992) 515-523
13. Ho M., Sexton M., Tongtawe P., Looareesuwan S., Suntharasamai P., and Webster H. Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria. J. Infect. Dis. 172 (1995) 838-844
14. Kern P., Hemmer C., Van Damme J., Gruss H., and Dietrich M. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am. J. Med. 87 (1989) 139-143
15. Kojima S., Nagamine Y., Hayano M., Looareesuwan S., and Nakanishi K. A potential role of interleukin 18 in severe falciparum malaria. Acta Trop. 89 (2004) 279-284
16. Langhorne J., Cross C., Seixas E., Li C., and von der Weid T. A role for B cells in the development of T cell helper function in a malaria infection in mice. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 1730-1734
17. Langouet S., Corcos L., Abdel-Razzak Z., Loyer P., Ketterer B., and Guillouzo A. Up-regulation of glutathione S-transferases alpha by interleukin 4 in human hepatocytes in primary culture. Biochem. Biophys. Res. Commun. 216 (1995) 793-800
18. Loyer P., Ilyin G., Abdel Razzak Z., Banchereau J., Dezier J., Campion J., Guguen-Guillouzo C., and Guillouzo A. Interleukin 4 inhibits the production of some acute-phase proteins by human hepatocytes in primary culture. FEBS Lett. 336 (1993) 215-220
19. Luoni G., Verra F., Arca B., Sirima B., Troye-Blomberg M., Coluzzi M., Kwiatkowski D., and Modiano D. Antimalarial antibody levels and IL4 polymorphism in the Fulani of West Africa. Genes Immun. 2 (2001) 411-414
20. Luty A., Perkins D., Lell B., Schmidt-Ott R., Lehman L., Luckner D., Greve B., Matousek P., Herbich K., Schmid D., Weinberg J., and Kremsner P. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect. Immun. 68 (2000) 3909-3915
21. Miller L., Baruch D., Marsh K., and Doumbo O. The pathogenic basis of malaria. Nature 415 (2002) 673-679
22. Nakashima H., Miyake K., Inoue Y., Shimizu S., Akahoshi M., Tanaka Y., Otsuka T., and Harada M. Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun. 3 (2002) 107-109
23. Perkmann T., Winkler H., Graninger W., Kremsner P.G., and Winkler S. Circulating levels of the interleukin (IL)-4 receptor and of IL-18 in patients with Plasmodium falciparum malaria. Cytokine 29 (2005) 153-158
24. Perry J., Olver C., Burnett R., and Avery A. Cutting edge: the acquisition of TLR tolerance during malaria infection impacts T cell activation. J. Immunol. 174 (2005) 5921-5925
25. Rattanarithikul R., Konishi E., and Linthicum K.J. Detection of Plasmodium vivax and Plasmodium falciparum circumsporozoite antigen in anopheline mosquitoes collected in southern Thailand. Am. J. Trop. Med. Hyg. 54 (1996) 114-121
26. Rihet P., Traore Y., Abel L., Aucan C., Traore-Leroux T., and Fumoux F. Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. Am. J. Hum. Genet. 63 (1998) 498-505
27. Riley E., Jakobsen P., Allen S., Wheeler J., Bennett S., Jepsen S., and Greenwood B. Immune response to soluble exoantigens of Plasmodium falciparum may contribute to both pathogenesis and protection in clinical malaria: evidence from a longitudinal, prospective study of semi-immune African children. Eur. J. Immunol. 21 (1991) 1019-1025
28. Rockman M., Hahn M., Soranzo N., Goldstein D., and Wray G. Positive selection on a human-specific transcription factor binding site regulating IL4 expression. Curr. Biol. 13 (2003) 2118-2123
29. Rosenwasser L., Klemm D., Dresback J., Inamura H., Mascali J., Klinnert M., and Borish L. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin. Exp. Allergy 25 Suppl. 2 (1995) 74-78
30. Singhasivanon P., Kidson C., and S S. Mekong Malaria II: update on malaria, multi-drug resistance and economic development in the Mekong region of Southeast Asia. Southeast Asia J. Trop. Med. Pub. Health 34 Suppl. 4 (2003) 63-64
31. Spilianakis C., Lalioti M., Town T., Lee G., and Flavell R. Interchromosomal associations between alternatively expressed loci. Nature 435 (2005) 637-645
32. Stevenson M., Tam M., Wolf S., and Sher A. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155 (1995) 2545-2556
33. Torre D., Speranza F., Giola M., Matteelli A., Tambini R., and Biondi G. Role of Th1 and Th2 cytokines in immune response to uncomplicated Plasmodium falciparum malaria. Clin. Diagn. Lab. Immunol. 9 (2002) 348-351
34. Udomsangpetch R., Chivapat S., Viriyavejakul P., Riganti M., Wilairatana P., Pongponratin E., and Looareesuwan S. Involvement of cytokines in the histopathology of cerebral malaria. Am. J. Trop. Med. Hyg. 57 (1997) 501-506
35. World Health Oganization. Severe and complicated malaria. Trans. Roy. Soc. Trop. Med. Hyg. 94 Suppl. (2000) 51-90